Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 12925
TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741059(S-(2-((5-((6-carbamoyl-4-(3-chloro-4-(3-cyclopropy...)
Affinity DataIC50: 0.960nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741073(S-(7-((6-carbamoyl-4-(3-chloro-4-(3-cyclopropylure...)
Affinity DataIC50: 2.60nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741066(S-(3-((3-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 3.20nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741060(S-(2-((5-((6-carbamoyl-4-(2-fluoro-4-(1-((4-fluoro...)
Affinity DataIC50: 4.60nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741067(N-(3-fluoro-4-((7-(3-((3-mercaptopropyl)(methyl)am...)
Affinity DataIC50: 4.70nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741064(S-(3-((3-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 6.60nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741065(N-(3-fluoro-4-((7-(3-((3-mercaptopropyl)amino)prop...)
Affinity DataIC50: 7.70nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741059(S-(2-((5-((6-carbamoyl-4-(3-chloro-4-(3-cyclopropy...)
Affinity DataIC50: 8.94nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741055(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 12nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741070(S-(2-((5-((4-(4-(1-((4-fluorophenyl)carbamoyl)cycl...)
Affinity DataIC50: 13nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741054(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 15.4nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741056(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 16.3nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741056(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 17nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741048(N-(3-fluoro-4-((7-(7-mercaptoheptyloxy)-6-methoxyq...)
Affinity DataIC50: 18nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741053(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 20nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741054(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 25nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741060(S-(2-((5-((6-carbamoyl-4-(2-fluoro-4-(1-((4-fluoro...)
Affinity DataIC50: 27nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741058(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 28.8nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741055(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 29.9nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741071(S-(2-((5-((4-(4-(1-(cyclopropylcarbamoyl)cycloprop...)
Affinity DataIC50: 30nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741069(S-(2-(3-(2-((4-(2-fluoro-4-(1-((4-fluorophenyl)car...)
Affinity DataIC50: 30nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741063((E)-N-(3-fluoro-4-((7-((6-mercaptohexyl-2-en-1-yl)...)
Affinity DataIC50: 33nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741049((E)-N-(3-fluoro-4-((7-((7-mercaptoheptyl-2-en-1-yl...)
Affinity DataIC50: 34.8nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741057(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 36nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741046(N-(3-fluoro-4-((7-(6-mercaptohexyloxy)-6-methoxyqu...)
Affinity DataIC50: 39.4nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741051((E)-N-(3-fluoro-4-((7-((5-mercaptoheptyl-2-en-1-yl...)
Affinity DataIC50: 42.4nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741072(S-(2-((5-((6-carbamoyl-4-(4-(1-(cyclopropanylcarba...)
Affinity DataIC50: 45nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741053(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 48.3nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741058(N-(3-fluoro-4-((7-((5-(2-mercaptoacetylamino)penty...)
Affinity DataIC50: 51nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741068(N-(3-fluoro-4-((7-(3-((5-thio-1,3,4-trithiazol-2-y...)
Affinity DataIC50: 54nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741062(N-(3-fluoro-4-((7-(4-mercaptobutoxy)-6-methoxyquin...)
Affinity DataIC50: 57nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741045(S-(6-((4-(2-fluoro-4-(1-((4-fluorophenyl)aminoform...)
Affinity DataIC50: 66nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741047(S-(7-((4-(2-fluoro-4-(1-((4-fluorophenyl)aminoform...)
Affinity DataIC50: 67.8nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741049((E)-N-(3-fluoro-4-((7-((7-mercaptoheptyl-2-en-1-yl...)
Affinity DataIC50: 79nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741061(S-(3-((4-(2-fluoro-4-(1-((4-fluorophenyl)aminoform...)
Affinity DataIC50: 79nMAssay Description:Detect compounds on VEGFR2 (KDR) by mobility shift assay. The initial test concentration of a compound was 1000 nM, 3 times dilution, 10 concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741050((E)-S-(5-((4-(2-fluoro-4-(1-((4-fluorophenyl)amino...)
Affinity DataIC50: 96.5nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM741057(S-(2-((5-((4-(2-fluoro-4-(1-((4-fluorophenyl)carba...)
Affinity DataIC50: 97.8nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Primegene (Beijing)

US Patent
LigandPNGBDBM50021574(CHEBI:72317 | CABOZANTINIB | BMS-907351 | Cometriq...)
Affinity DataIC50: 1.00E+4nMAssay Description:Prepare a 10 mM stock solution of a compound with DMSO. Take 10 μl of stock solution and dilute with 90 μl DMSO to become a 1 mM working solution. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent